Le Lézard
Classified in: Health
Subject: CHI

The Beryl Institute Announces Launch of Patient Experience Pediatric Council


DALLAS, Feb. 20, 2019 /PRNewswire-PRWeb/ -- In expanding its commitment to improving the patient experience through collaboration and shared knowledge, The Beryl Institute introduces the Pediatric Council. The Institute's Pediatric Council represents a group of individuals committed to engaging with one another, sharing ideas and expanding the engagement of pediatric patient experience leaders in The Beryl Institute community.

Members of the Institute's Pediatric Council are passionate about the advancement of pediatric patient experience and ensuring resources are available to support pediatric leaders in advancing the human experience in healthcare. The Pediatric Council will guide program development and advise The Beryl Institute on topics of relevance and issues pertaining to pediatric leaders and staff.

"As we continue to expand the reach of the Institute we remain committed to engaging leading thinkers in the field of Patient Experience to help guide us on our ongoing journey," said Jason Wolf, President, The Beryl Institute. "Our volunteer leaders help ensure The Beryl Institute remains a valuable and innovative source of research, resources and connections."

Complementing the Institute's other boards and councils, Pediatric Council members each serve in a patient experience related role for a children's healthcare provider organization and include:

Co-Chairs:

Council Members:

For more information on the Pediatric Council of The Beryl Institute, visit: https://www.theberylinstitute.org/page/PEDCOUNCIL

About The Beryl Institute:
The Beryl Institute is the global community of practice dedicated to improving the patient experience through collaboration and shared knowledge. We define patient experience as the sum of all interactions, shaped by an organization's culture, that influence patient perceptions across the continuum of care.

 

SOURCE The Beryl Institute


These press releases may also interest you

at 07:15
IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the "Company" or "IPA") , InterSystems, a creative data technology provider dedicated to helping customers solve their most critical scalability, interoperability, and speed challenges, together with ImmunoPrecise...

at 07:10
Can-Fite BioPharma Ltd. , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced financial results and clinical updates for the twelve months ended...

at 07:10
Kelonia Therapeutics, a biotech company revolutionizing in vivo gene delivery, today announced the appointments of global leaders in cell therapy and drug development, Kristen Hege, M.D., and Mathai Mammen, M.D., Ph.D., to its board of directors....

at 07:05
Aldeyra Therapeutics, Inc. (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced the clinical development plan intended to enable...

at 07:05
Mythic Therapeutics, a clinical-stage biotechnology company committed to the development of next-generation antibody-drug conjugate (ADC) therapies for the treatment of a wide range of cancers, announced that George Eliades, Ph.D., has joined the...

at 07:05
Seres Therapeutics, Inc. ("Seres" or the "Company"), a leading microbiome therapeutics company, today announced that on March 25, 2024, the Compensation and Talent Committee of Seres' board of directors granted inducement equity grants covering an...



News published on and distributed by: